史維德氏症候群(Sweet syndrome)是一種伴隨急性發燒、疼痛像水泡之病灶的疾病。對類固醇的治療反應很好。這一直是皮膚科中相當神秘的一種疾病,直到近幾年來隨著對細胞激素(cytokines)的研究漸多,才比較了解可能的致病機轉以及跟其他發炎性疾病/癌症/藥物的關聯。
Chapter 36 :: Sweet Syndrome
:: Philip R. Cohen & Razelle Kurzrock
鄭煜彬(20200301)
| 
DEFINITION | |
| 
What is the typical features of Sweet
  syndrome(SS)?  | 
1.         
  Acute onset of pyrexia &
  painful skin lesions   
2.         
  Dense dermal infiltrate of
  mature neutrophils 
3.         
  Promptly resolve after
  systemic steroids. | 
| 
What are the inflammatory (neutrophilic)
  diseases in dermatology?  | 
SS, pyoderma gangrenosum, subcorneal
  pustular dermatosis, Bowel bypass syn., erythema elevatum diutinum,
  neutrophilic eccrine hidradenitis, rheumatoid neutrophilic dermatitis, autoinflammatory
  diseases (Schnitzler syn., Blau syn., PAPA syn., SAPHO syn….)  | 
| 
EPIDEMIOLOGY | |
| 
What is the common onset age & gender
  of SS?  | 
30-60 y/o, female | 
| 
What is 3 types of SS according to the causes?
   | 
Classical, malignancy-associated, &
  drug-induced | 
| 
CLINICAL FEATURES | |
| 
HISTORY | |
| 
What is the general appearance of SS?  | 
Dramatically ill + fever + skin eruption ± arthralgia,
  general malaise, headache, & myalgia | 
| 
What is the time sequence between skin
  eruption of SS & fever?  | 
Concurrently present with the fever or
  follow the fever by several days to weeks. | 
| 
CUTANEOUS FINDINGS | |
| 
LESION MORPHOLOGY | |
| 
What is the morphology of the lesions of
  SS  | 
Single or multiple, asymmetrically
  distributed,  tender, red/purple-red,
  papules/nodules with transparent,
  vesicle-like appearance (illusion of vesiculation = edema in the upper
  dermis) | 
| 
What is the change of lesions of SS in
  the later stages?  | 
1.         
  Central clearing→annular or arcuate
  patterns (targetoid) 
2.         
  Enlarging→coalesce & form
  irregular sharply bordered plaques | 
| 
What is the features of malignancy-associated
  SS?  | 
Bullous or ulcerated lesions, and/or
  mimic pyoderma gangrenosum.  | 
| 
What is the result of SS lesions? | 
The lesions resolve without scar.  | 
| 
What is the percentage of SS with
  recurrence | 
1/3-2/3 of the cases has recurrent
  episodes. | 
| 
CUTANEOUS PATHERGY & ISOTOPIC
  RESPONSE | |
| 
What is the cutaneous pathergy of SS?  | 
Skin hypersensitivity at sites of trauma
  during the episodes of SS= isotopic (Koebner) response  | 
| 
What may induce isotopic response of SS?  | 
Wounds, sunburn(phototoxic reaction→photo distributed),
  radiation therapy or tattoo | 
| 
What is the Wolf’s isotopic response of
  SS?  | 
New lesions at the site of another
  unrelated & already healed skin disease. (Lymphedematous leg,
  postmastectomy arm, & zoster. ) | 
| 
What is the other variants of SS?  | 
1.         
  Pustular dermatosis 
2.         
  Neutrophilic dermatosis of
  the dorsal hands 
3.         
  Subcutaneous panniculitis 
4.         
  Histiocytoid variant 
5.         
  Giant cellulitis-like variant | 
| 
What is the features of pustular dermatosis of SS? | 
Tiny pustules on the tops of red papules
  or erythematous-based pustules. (±ulcerative colitis:) | 
| 
What is the features of neutrophilic dermatosis of the dorsal
  hands of SS? | 
1.         
  A localized, pustular variant
  at dorsal hands.  
2.         
  Rapid resolution under steroids
  & dapsone.  
3.         
  Concurrent oral mucosa, arm,
  leg, back, &/or face lesions. | 
| 
What is the features of subcutaneous panniculitis of SS? | 
1.         
  Erythematous, tender dermal
  nodules on the limbs, mimic erythema
  nodosum on the legs 
2.         
  In 80% of SS (not rare).  | 
| 
What is the features of histiocytoid variant of SS?  | 
1.         
  Looks like typical SS, but
  the dermal infiltrate is composed of “histiocytic” mononuclear cells (presenting immature myeloid cells). 
2.         
  Associated with malignancy | 
| 
What medicine may induce histiocytoid SS?
   | 
Bortezomib | 
| 
What is the features of giant cellulitis-like variant of  SS? | 
1.         
  Relapsing widespread giant
  lesions 
2.         
  F>>M, 48-72 years
  (median = 61 years) 
3.         
  Upper leg & buttocks:
  most common 
4.         
  Patients are obese (2/3)
  & has cancer (1/2) | 
| 
What is the features of necrotizing variant of SS? | 
1.         
  Rapid onset of edematous,
  erythematous, warm lesions→necrotizing fasciitis like lesions 
2.         
  A deep-tissue neutrophilic
  infiltration + soft-tissue necrosis. | 
| 
NONCUTANEOUS FINDINGS | |
| 
What are the sites of non-cutaneous SS? | 
The bones, CNS/eyes, ears, kidneys,
  intestines, liver, heart, lung, mouth, muscles, & spleen/lymph nodes | 
| 
What is the cardiac involvement of SS? | 
1.         
  Children: postinflammatory
  elastolysis (heart & aorta) & Takayasu arteritis. (rare) 
2.         
  Adult: coronary artery
  occlusion (rare) | 
| 
What is the CNS involvement (neuro-Sweet
  disease, nSd) of SS? | 
1.         
  Self-remitting/reversible parkinsonism 
2.         
  Eyes: optic nerve involvement
  + panuveitis, endogenous endophthalmitis + chorioretinitis 
3.         
  Radiation therapy-induced nSd | 
| 
What is the oral involvement of SS? | 
1.         
  Ulcers (in SS with
  hematologic disorders, uncommon in classical SS, resolve s/p steroid. | 
| 
What is the otic involvement of SS? | 
Progressive sensorineural hearing loss | 
| 
COMPLICATIONS | |
| 
What are the complications of SS?  | 
1.         
  Directly related: secondary
  infections (thus antimicrobial therapy is in need) 
2.         
  Indirectly related: inflammatory
  bowel disease, sarcoidosis, thyroid dz, & malignancies.  | 
| 
What is the meaning of reappearance of
  the dermatosis in malignancy-associated SS?  | 
Recurrence of the malignancy | 
| 
ETIOLOGY AND  
PATHOGENESIS | |
| 
ASSOCIATED CONDITIONS 
ASSOCIATED DISEASES | |
| 
What are the etiologically-related
  conditions occur before, concurrent with, or following the diagnosis of SS | 
BRIT.
  PRICES: Behçet disease, cancer, erythema nodosum,
  infections, inflammatory bowel disease, pregnancy, relapsing polychondritis,
  rheumatoid arthritis, sarcoidosis, & thyroid dz | 
| 
What is the “differentiation syndrome”
  associated with SS?  | 
An inflammatory reaction with↑capillary
  permeability, in up to 25% of patients with acute promyelocytic leukemia
  treated with all-trans-retinoic acid.(=retinoic acid syndrome) | 
| 
What is the associated conditions of
  histiocytoid variant?  | 
Medications, autoimmune diseases,
  infections & inflammation, inflammatory bowel disease, & malignancy | 
| 
What is the associated conditions of
  giant cellulitis-like variant? | 
Obesity & malignancy | 
| 
What is the malignancies in the giant
  cellulitis-like variant? | 
Hematologic dyscrasia (multiple myeloma
  or myelodysplastic syndrome/myeloproliferative disorder) & breast cancer | 
| 
ASSOCIATED NEUTROPHILIC  
DERMATOSES | |
| 
What is the characteristic of neutrophilic
  dermatoses?  | 
An inflammatory infiltrate of mature PMN. | 
| 
What is the associated neutrophilic
  dermatoses of SS?  | 
Erythema elevatum diutinum, neutrophilic
  eccrine hidradenitis, pyoderma gangrenosum, subcorneal pustular dermatosis, &/or
  vasculitis.  | 
| 
How to differentiate SS & other
  neutrophilic dermatoses?  | 
According to the location of the lesions.
   | 
| 
CONCURRENT LEUKEMIA CUTIS | |
| 
What are the relationship between SS
  & other malignancies?  | 
1.         
  SS exist as a paraneoplastic
  syndrome  
2.         
  SS appears with hematologic
  disorders concurrently.  | 
| 
What is the most frequent hematologic
  dyscrasias associated with leukemia cutis (abnormal Nφ) & SS (mature
  PMN)? | 
1.         
  Acute myelocytic leukemia
  & acute promyelocytic leukemia 
2.         
  (Less common) myelodysplastic
  syndrome, chronic myelogenous leukemia, myelogenous leukemia | 
| 
What are the culprit drugs of SS?   | 
All-trans-retinoic acid, bortezomib,
  granulocyte colony-stimulating factor (G-CSF), or imatinib mesylate | 
| 
What is the most notorious drug to induce
  SS?  | 
G-CSF | 
| 
What is the mechanisms of concurrent Sweet
  syndrome & leukemia cutis?  | 
1.         
  Secondary leukemia cutis: the
  circulating immature myeloid precursor cells are recruited to the
  inflammatory oncotactic environment stimulated by SS. 
2.         
  Primary leukemia cutis: the
  leukemic cells constitute the bonified incipient, or G-CSF induced
  differentiation of atypical leukemia cells into mature Nφ.   | 
| 
What is the most threatening associated
  disease of SS?   | 
Systemic inflammatory response syndrome
  (SIRS) | 
| 
PATHOGENESIS | |
| 
What is the possible causes of SS?  | 
1.         
  A hypersensitivity reaction
  to an eliciting bacterial, viral, or tumor antigen (preceding febrile URI or
  tonsillitis, SS with Yersinia enterocolitica improves after antibiotic ) 
2.         
  HLA serotypes: non-B54 types
  HLA 
3.         
  Cytokines: IL-1, 3, 6, 8, 17,
  & TNF-α, IFN-γ, G-CSF & IL-6(MDS-associated SS), GM-CSF (classical
  SS), G-CSF (acute myelogenous leukemia-associated SS & neutrophilic
  panniculitis) 
4.         
  CD4+ T-cell dysfunction(TH1) 
5.         
  Autoantibodies to
  neutrophilic cytoplasmic antigens  | 
| 
What disease resemble SS and may share
  the same pathogenesis?  | 
Familial Mediterranean fever: share the
  same mutated gene with chronic myelogenous leukemia associated SS. | 
| 
PHOTOSENSITIVITY | |
| 
What drug may induce photodrug-associated
  SS?  | 
trimethoprim-sulfamethoxazole | 
| 
Why does UV(B) induce SS?    | 
1.         
  UV(B) induces isomorphic(Koebner)
  reaction 
2.         
  UV(B) induces Nφ& production of
  TNF-α & IL-8. | 
| 
DIAGNOSIS 
DIAGNOSTIC CRITERIA | |
| 
What is the diagnostic criteria for
  classical SS?  | 
1          
  Abrupt onset of painful
  erythematous plaques or nodules 
2          
  Hx:
  a dense Nφinfiltrate w/o LCV 
3          
  Pyrexia >38°C (100.4°F) 
4          
  Association with an
  underlying  
4.1        
  hematologic (AML)  
4.2        
  visceral malignancy (GU organs, breast, & GI), inflammatory dz
  (Crohn dz & ulcerative colitis) 
4.3        
  pregnancy 
4.4        
  preceded by an upper respiratory (streptococcosis)
  or GI (salmonellosis &
  yersiniosis) infection or
  vaccination 
5          
  Excellent response to
  systemic corticosteroids or potassium iodide(KI) 
6          
  Abnormal Lab values at
  presentation (3 of 4): ESR >20 mm/h; CRP(+); >8000/µL leukocytes;
  >70% Nφ | 
| 
What is the diagnostic criteria for
  drug-induced SS? | 
1, 2, 3 as classical SS  
4. Temporal relationship between drug
  & clinical presentation, or temporally related recurrence after oral
  challenge 
5. Temporally related resolution of
  lesions after drug withdrawal or tx with systemic steroid | 
| 
SUPPORTIVE STUDIES | |
| 
LABORATORY TESTING | |
| 
What should we check in SS? | 
CBC/DC(Peripheral leukocytosis +
  neutrophilia, -penia in malignancy), ESR/CRP(↑), GOT/GPT(↑), CREA/BUN(↑), urinalysis(hematuria
  and proteinuria), thyroid function(hypo- or hyper-), CSF analysis. | 
| 
PATHOLOGY  | |
| 
What is the features of pathology of SS?  | 
A diffuse/dense infiltrate of mature Nφ is present in the
  papillary and upper reticular dermis, even in epidermis(spongiosis/subcorneal
  pustules) or adipose tissue ± secondary LCV (no fibrin deposition & Nφ in the wall) ± concurrent
  leukemia cutis | 
| 
What study should be performed with the
  biopsy?  | 
Bacterial, fungal, mycobacterial, &
  viral culture | 
| 
What is the features of histiocytoid SS?  | 
Dermal infiltrate composed of immature
  granulocytes (histiocytic mononuclear cells, similar to Nφ but has CD15, 43,
  45 (LCA), 68, HAM56, lysozyme, & MAC 387) | 
| 
What cells are contained in the
  infiltrate of SS?  | 
Nφ(mature or
  abnormal), lymphocytes or histiocytes, Eφ(drug-induced or
  malignancy-associated) | 
| 
IMAGING | |
| 
What image study should be performed in
  SS?  | 
Brain: PET/CT, CT, MRI, EEG, MRI 
Neutrophilic fasciitis/musculoskeletal:
  MRI 
Pleural effusions: CXR | 
| 
DIFFERENTIAL DIAGNOSIS | |
| 
CLINICAL DIFFERENTIAL  
DIAGNOSIS | |
| 
What are the differential diagnoses of
  SS?  | 
infectious & inflammatory disorders,
  neoplastic conditions, reactive erythemas, vasculitis, Behçet disease, azathioprine
  hypersensitivity reaction, chronic atypical neutrophilic dermatosis with
  lipodystrophy & elevated temperature (CANDLE) syndrome, &
  gemcitabine-associated Sweet syndrome-like eruptions, arthropod bite | 
| 
How to differentiate Behçet disease &
  Sweet syndrome?  | 
Human leukocyte antigen analysis 
B51: Behçet disease; B54: SS | 
| 
What are the differential diagnoses of
  giant cellulitis-like SS?  | 
Cellulitis & periodic syndromes (such
  as familial Mediterranean fever) | 
| 
HISTOLOGIC DIFFERENTIAL  
DIAGNOSIS | |
| 
How to differentiate SS & leukemia
  cutis? | 
Leukemia cutis has malignant immature
  leukocytes. | 
| 
How to differentiate SS & neutrophilic
  lobular pannicu 
litis? | 
SS had infiltratein the lobules, the
  septae, or both. | 
| 
What diseases should be differentiate
  with histiocytoid SS? | 
Leukemia cutis, interstitial type of
  granuloma annulare, interstitial granulomatous dermatitis with arthritis,
  & methotrexate-induced rheumatoid papules | 
| 
CLINICAL COURSE AND  
PROGNOSIS | |
| 
What is the natural course of SS ? | 
Resolves spontaneously, but lesions persist
  for weeks to months. | 
| 
What is the course of malignancy-associated
  or drug-induced SS?  | 
Clearing after successful management of
  the cancer or discontinuation of the associated medication. | 
| 
What is the successful management of
  tonsillitis, solid tumors, or renal failure-induced SS?  | 
Surgical excision or transplantation of
  kidney.  | 
| 
What patients has higher recurrence of
  SS?  | 
Malignancy-associated SS.  | 
| 
MANAGEMENT 
MEDICATIONS 
FIRST-LINE TREATMENTS | |
| 
What is the first line treatments of SS?  | 
Systemic/topical/IL corticosteroids, potassium
  iodide & colchicine | 
| 
How to treat refractory SS with steroids?
   | 
Daily, IV pulse methylprednisolone  | 
| 
How to treat localized SS with steroids?  | 
Topical (0.05% clobetasol propionate) or IL
  (triamcinolone acetonide, 3-10 mg/cc)  | 
| 
What is the side effects of KI?  | 
Vasculitis & hypothyroidism | 
| 
What is the side effects of colchicine?  | 
GI symptoms: diarrhea, abdominal pain,
  nausea & vomiting | 
| 
What is the dose of KI tablet?  | 
300 mg enteric-coated tablet, 1 tablet
  tid (900mg/day) | 
| 
What is the usage of SSKI (saturated solution
  of KI,  Lugol's solution) | 
1 drop = 0.05 ml  
3 drops tid (450mg/day)→↑by 1drop 3 times
  each day→7-10 drops tid
  (1050-1500 mg/day) | 
| 
What is the concentration of SSKI in SS?  | 
1 g KI /ml of water(1 drop = 0.05 ml =
  50mg) | 
| 
SECOND-LINE TREATMENTS | |
| 
What drugs can be second-line treatments
  of SS(4)?  | 
Indomethacin, clofazimine, cyclosporine,
  & dapsone | 
| 
Which 2 drugs can be used in the
  combination therapy with steroids?  | 
Cyclosporine & dapsone | 
| 
ANTIBIOTICS | |
| 
What are the proper antibiotics used in
  the treatment of SS-related infections?   | 
Secondarily impetiginized lesions: abx
  for S. aureus 
Inflammatory bowel disease: metronidazole 
Yersinia or Chlamydia: doxycycline,
  minocycline,  
or tetracycline | 
| 
OTHER AGENTS | |
| 
What are other choice of treatments of
  SS?  | 
l   Antineoplastic (azacitidine, chlorambucil, cyclophosphamide, &
  rituximab) 
l   TNF inhibitors (adalimumab, etanercept, infliximab, & thalidomide) 
l   Miscellaneous: danazol, etretinate, hepatitis therapy, IVIG,
  IFN-α, Anakinra(+steroid) | 
| 
MALIGNANCY WORKUP | |
| 
Why should we work up malignancies in patients
  with SS?  | 
Neoplasms concurrently present or
  subsequently develop in previously cancer-free SS | 
 

 
No comments:
Post a Comment